| HOME >> MEDICINE >> TECHNOLOGY |
THORATEC CORPORATIONReconciliation of GAAP to Non-GAAP Gross Profit from Continuing Operations(Unaudited)(in thousands) Three Months Ended Six Months Ended July 2, 2011July 3, 2010July 2, 2011July 3, 2010Gross profit from continuing operations on a GAAP basis$
78,811
70.9%
$
4,519
67.8%$
48,606
70.5%
$
32,220
68.0%Share-based compensation expense
373359703626Gross profit from continuing operations on a non-GAAP basis
$
79,184
71.2%
$
4,878
68.2%$
49,309
70.8%
$
32,846
68.3%The following table reconciles the specific items excluded from GAAP operating expenses from continuing operations in the calculation of non-GAAP operating expenses from continuing operations for the periods shown below:
THORATEC CORPORATIONReconciliation of GAAP to Non-GAAP Operating Expenses from Continuing Operations(Unaudited)(in thousands) Three Months Ended Six Months Ended July 2, 2011July 3, 2010July 2, 2011July 3, 2010Operating expenses from continuing operations on a GAAP basis$
44,555$
35,345$
87,265$
79,589Share-based compensation expense:- Selling, general and administrative(2,509)(1,895)(5,038)(4,216)- Research and development(958)(809)(2,062)(1,811)Amortization of purchased intangibles(2,197)(2,468)(4,499)(4,881)Levitronix transaction costs(1,392)-(1,398)-Operating expenses from continuing operations on a non-GAAP basis $
37,499$
30,173$
74,268$
8,681The following table reconciles the specific items excluded from GAAP other income and expense from continuing operations in the calculation of non-GAAP other income and expense from continuing operations for the periods shown below:
THORATEC CORPORATIONReconciliation of GAAP to Non-GAAP Other Income and Expense
'/>"/>
| SOURCE Thoratec Corporation Copyright©2010 PR Newswire. All rights reserved |